Related Experiment Videos
Platelet size in myocardial infarction
Insights
Patients after myocardial infarction show increased mean platelet volume, suggesting abnormal platelet activity contributes to infarction. Platelet counts were initially lower but normalized over time.
Area of Science:
- Cardiology
- Hematology
- Pathophysiology
Background:
- Platelets play a crucial role in hemostasis and thrombosis.
- Abnormal platelet function is implicated in cardiovascular diseases.
- Myocardial infarction (MI) is a leading cause of mortality worldwide.
Purpose of the Study:
- To investigate serial changes in mean platelet volume (MPV) and platelet count in patients following myocardial infarction.
- To compare these parameters with age-matched healthy controls.
- To explore the potential role of platelet characteristics in the pathophysiology of MI.
Main Methods:
- Serial measurements of MPV and platelet count were performed on 100 MI patients.
- Patients were assessed shortly after infarction and at a follow-up clinic (approx. 7 weeks later).
- Data were compared against age-matched control subjects.
Main Results:
- Mean platelet volume was significantly higher in MI patients (9.07 fl) compared to controls (8.32 fl) and remained elevated at follow-up (8.69 fl).
- Mean platelet count was significantly lower in MI patients (275 x 10(9)/l) on admission compared to controls (295 x 10(9)/l).
- Platelet count decreased significantly during hospitalization but returned to near-admission levels by follow-up.
Conclusions:
- Elevated mean platelet volume post-myocardial infarction suggests increased platelet activity.
- Larger platelets are known to be more hemostatically active, supporting their role in infarction.
- These findings provide further evidence implicating abnormal platelet behavior in the process of myocardial infarction.
Abstract:
The mean platelet volume and platelet count were measured serially in 100 patients soon after myocardial infarction and again at a follow up clinic about seven weeks later. The results were compared with those in age matched controls. The mean platelet volume after infarction (mean 9.07 fl (SE 0.08] was significantly greater than in the controls (8.32 fl (SE 0.07); p less than 0.001), and was still raised at the follow up clinic (8.69 fl (SE 0.10); p less than 0.01). The mean platelet count on admission (275 X 10(9)/1 (SE 7] was significantly lower than in the control group (295 X 10(9)/1 (SE 5); p less than 0.05) and fell significantly during admission, with a mean change of -36 X 10(9)/1 (95% confidence limits -26, -45; p less than 0.01). At the follow up clinic the platelet count had risen to a level not significantly different from the admission value. As larger platelets are haemostatically more active, the finding of an increased mean platelet volume after myocardial infarction provides further evidence that abnormal platelet behaviour may be implicated in the process of infarction.